Finance

Beta
Lists
187660:KOSDAQ
Penetrium Bioscience Inc
â‚©4,805.00
+2.13%
(+100.00) 1D
Jul 3, 3:30:23 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 187660...
Open
â‚©4,615
High
â‚©4,980
Low
â‚©4,520
Mkt. cap
307.36B
Avg. vol.
962.87K
Volume
318.50K
52-wk high
â‚©20,844
52-wk low
â‚©1,106
EPS
-â‚©246
Shares outstanding
55.47M
No. of employees
110
Open
â‚©4,615
High
â‚©4,980
Low
â‚©4,520
Mkt. cap
307.36B
Avg. vol.
962.87K
Volume
318.50K
52-wk high
â‚©20,844
52-wk low
â‚©1,106
EPS
-â‚©246
Shares outstanding
55.47M
No. of employees
110
News stories
From sources across the web
About Penetrium Bioscience Inc
CEOJong-Eon Lim
Employees110
Founded2003
Headquarters-
SectorHealth care
Websitehdadmbio.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2024
Sep 2024
Dec 2024
Revenue
2.63B
2.04B
-
Cost of goods sold
2.39B
2.29B
-
Cost of revenue
2.39B
2.29B
-
Research and development expenses
9.33B
1.03B
-
Total research and development expenses
-
-
-
Selling, general, and admin expenses
1.19B
987.24M
-
Operating expense
10.80B
2.33B
-
Total operating expenses
13.19B
4.62B
-
Operating income
-10.57B
-2.58B
-
Other non operating income
-2.16B
-79.27M
-
EBT including unusual items
-12.67B
-3.79B
-
EBT excluding unusual items
-12.56B
-3.03B
-
Income tax expense
54.99M
-
-
Effective tax rate
-0.43%
-
-
Other operating expenses
30.78M
41.01M
-
Net income
-12.48B
-3.57B
-
Net profit margin
-475.14%
-174.38%
-
Earnings per share
-
-
-
Interest and investment income
213.71M
70.18M
-
Interest expense
-73.78M
-448.74M
-
Net interest expenses
139.93M
-378.56M
-
Depreciation and amortization charges
208.24M
234.15M
-
EBITDA
-10.15B
-2.18B
-
Gain or loss from assets sale
-
742.90M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer